Journal of Gynecologic Oncology

Papers
(The TQCC of Journal of Gynecologic Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines89
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity38
Prognostic significance of para-aortic node metastasis in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis30
Step-by-step demonstration of “sciatic-nerve-preserved beyond-LEER” in a Thiel-embalmed cadaver: a novel salvage surgery for recurrent gynecologic malignancies26
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial26
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles25
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?23
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies23
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer23
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study23
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients20
Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer19
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)16
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)15
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer15
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer14
Surgical technique of two-step pelvic and para-aortic sentinel lymph node mapping in early-stage endometrial cancer: laparoscopic, robotic, and open method14
Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer14
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study14
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use14
Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis13
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes13
ASGO 7th International Workshop on Gynecologic Oncology13
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer12
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women11
HPV vaccination among seropositive, DNA negative cohorts: a systematic review & meta-analysis11
Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary11
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling10
Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)10
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor10
Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study10
Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy10
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study10
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry9
Evaluation of CD4+ cells infiltration as a prognostic factor in cervical intraepithelial neoplasia 29
Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy9
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–20209
Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma9
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey9
Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer8
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey8
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer8
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study8
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study7
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group7
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over7
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 20237
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation7
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement7
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review7
Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis7
Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term wom6
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study6
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study6
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan6
Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study6
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study6
Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer6
PLIN2: a potential prognostic markers of early-stage atypical endometrial hyperplasia6
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec5
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines5
Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study5
Reviewer recognition in 20215
Expert commentary on HORSE/MITO18 and CHIPOR5
Author's reply to: Cisplatin versus carboplatin?5
Patient-reported symptom burden and circulating cytokines undergoing chemotherapy: a pilot study in patients with ovarian cancer5
Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA: first results from the multicentric TMMR register study5
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end5
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan5
HIPEC in recurrent ovarian cancer: flogging a tired HORSE?5
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study5
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome5
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.4
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model4
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting4
The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 20214
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study4
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data4
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis4
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer4
Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer4
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications4
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial4
A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer4
Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian canc4
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma4
Functions, interactions and prognostic role of POLE: a bioinformatics analysis4
Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer4
Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study4
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset4
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins4
Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Net3
Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary per3
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis3
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer3
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction3
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy3
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study3
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer3
Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines3
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, 3
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)3
Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study3
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors3
Revisiting the meaning of Trousseau sign and syndrome3
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome3
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review3
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers3
Epidemiologic study on gestational trophoblastic diseases in Japan3
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer3
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis3
The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma3
A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma3
0.089505910873413